Tele-Clinic Visits in Pediatric Marfan Patients Using Parental Echo: The Future?
NCT03581682 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2021-03-17
Summary
Marfan syndrome (MFS), a connective tissue disorder seen in 1 in 3,000 individuals, causes progressive aortic root dilation that can result in aortic dissection and sudden death. Clinical care focuses on monitoring the aortic root by serial echocardiography (echo) to guide medical treatment and elective aortic root surgery in a specialized clinic every 6-12 months. This monitoring protocol, coupled with surgical intervention, has doubled the median life expectancy which was previously only 32 years. However, this surveillance carries significant health care costs at \>$50 million dollars/year on echos alone (at $3-4K each) in children and adolescents in the US, as well as substantial burden on families residing far from specialized centers. A clinic visit delivered to MFS patients via live-video conferencing at home (tele-visit) could shift this paradigm, if a home echo could be obtained.
Here, the investigator will train parents of Pediatric Marfan patients to take echo images using a hand held device, height, weight, blood pressure, medical history, and listen to the heart of their child. Then, the investigators will ask them to take the equipment home and collect the same data at home during a tele-clinic visit, with further instruction by the study team through secure live-video conferencing.
Conditions
- Marfan Syndrome
Interventions
- OTHER
-
Tele-Clinic Visits Using Parent-Acquired Echos
Every patient will have a tele-visit and an on-site clinic visit 1 day apart 3-6 months after the training session. Parents will have a 1-hour hands-on training session to acquire basic echo images on their children with the same hand-held device that they will use during the tele-visit. The parents will also have an in-service on how to take weight, height, and blood pressure measurements, and how to use the digital stethoscope. A tele-visit will be schedule a day prior to the patient's regularly scheduled clinic visit. Tele-visit elements will include interim medical history by the parent and patient, and weight, height, vital signs, digital cardiac auscultation, and home echo, all obtained by the parent. Two MFS physicians, following our routine MFS care protocol, will administer either the tele-visit or on-site clinic visit, masked to the findings of the other.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Seda Tierney, MD · Stanford University
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 5 Years
- Max Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-07-01
- Primary Completion
- 2020-08-01
- Completion
- 2020-08-01
Countries
- United States
Study Locations
More Related Trials
-
Development of a Blood Test for Marfan Syndrome
NCT02148900 ·Status: UNKNOWN
-
Re-Energize Fontan
NCT04195451 ·Status: COMPLETED ·Phase: NA
-
Variability of Ventricular Mass, Volume, & Ejection Fraction in Pediatric Cardiomyopathy Patients-Pediatric Heart Network
NCT00123071 ·Status: COMPLETED
-
Fibrosis and the Fontan
NCT04901975 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Effects of Pulmonary Vasodilation Upon VA Coupling in Fontan Patients
NCT01607983 ·Status: WITHDRAWN ·Phase: PHASE3
-
Relationship Between Functional Health Status and Ventricular Performance After Fontan--Pediatric Heart Network
NCT00132782 ·Status: COMPLETED
-
Thoracic Aortic Dilatation Syndromes
NCT02111668 ·Status: COMPLETED
-
Effect of Fetal Aortic Valvuloplasty on Outcomes
NCT05386173 ·Status: RECRUITING
-
Fetal Cardiac Strain Imaging Research
NCT01993264 ·Status: COMPLETED
-
Heart Failure in Adult Patients With a History of Congenital Heart Disease
NCT00208754 ·Status: TERMINATED
-
Circulating Transforming Growth Factor Beta (TGF-β) in Individuals With Marfan Syndrome
NCT01361087 ·Status: WITHDRAWN ·Phase: PHASE3
-
Speckle Tracking Echocardiography in Infants, Prenatally and Postnatally
NCT05601375 ·Status: UNKNOWN
-
Mild Valvar Pulmonary Stenosis
NCT00277927 ·Status: TERMINATED
-
Association of Insulin Resistance and FGF21 on Cardiac Function in Pediatric Dilated Cardiomyopathy
NCT04222101 ·Status: TERMINATED ·Phase: NA
-
Long-term Outcomes of Children With Hypoplastic Left Heart Syndrome and the Impact of Norwood Shunt Type
NCT02455531 ·Status: ACTIVE_NOT_RECRUITING
-
PRecIsion Medicine in CardiomyopathY
NCT04036799 ·Status: ACTIVE_NOT_RECRUITING
-
Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome
NCT06342999 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Fetal Intervention for Aortic Stenosis and Evolving Hypoplastic Left Heart Syndrome
NCT01736956 ·Status: COMPLETED ·Phase: NA
-
Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)
NCT01873976 ·Status: UNKNOWN
-
Cardiac Performance Evaluation in Children With Steroid Dependent vs Steroid Resistant Nephrotic Syndrome
NCT06622915 ·Status: RECRUITING ·Phase: NA
-
Pediatric Cardiomyopathy Mutation Analysis
NCT02432092 ·Status: RECRUITING
-
Cerebral Anatomy, Hemodynamics and Metabolism
NCT02919956 ·Status: COMPLETED
-
Prospective Identification of Long QT Syndrome in Fetal Life
NCT02876380 ·Status: COMPLETED
-
Review of Descending Aortic Flow Reversal in Total Anomalous Pulmonary Venous Connection
NCT00486070 ·Status: TERMINATED
-
Clinical Characteristics and Associations of the "Good Fontan" Patient
NCT03470428 ·Status: COMPLETED